More relevant, in NAFLD patients, the rs1800849 UCP3 -55CT genotype was associated with insulin resistance, adiponectin levels, the presence of moderate-severe steatosis and NASH [167]. Here, ADIPOQ is linked to metabolic dysfunction-associated steatotic liver disease.